From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...
Two sustained-release procedural pharmaceuticals or drug-delivery options are available in the US: the bimatoprost ...
A new population-based study published in the journal of Advances in Therapy revealed that individuals diagnosed with ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
Q3 2025 Earnings Call October 29, 2025 4:30 PM EDTCompany ParticipantsChristopher Lewis - Vice President of Investor ...
Ellon has taken his South Sudanese blind soccer team a step closer to their dream of playing at the 2028 Paralympics in California. The 22-year-old striker is representing South Sudan’s “Bright Stars, ...
The Manila Times on MSN
South Sudan's blind football team dreams of Paralympic glory
Blind football uses a bell in the ball to direct players on the five-a-side teams, using the Spanish word "voy" ("I'm coming" ...
Among them, Lucentis® is the first anti-vascular endothelial growth factor (VEGF) drug approved for ophthalmic use in China, and has accumulated mature clinical application experience, providing ...
Horus Pharma inks agreement to commercialize Formycon’s aflibercept biosimilar FYB203 under the brand name Baiama across Key European Markets including its home market France ...
New rules are set to shake up how older drivers manage their licences from November 2025. If you’re 62 or over, the talk is about digital-first renewals, ...
Sheila Bautz Special to the Herald In an announcement earlier this month, the Saskatchewan Association of Optometrists (SAO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback